# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-170609
Filing Date
2013-04-24
Accepted
2013-04-24 17:02:13
Documents
6
Period of Report
2013-05-24
Effectiveness Date
2013-04-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | d487246ddef14a.htm | DEF 14A | 330271
2 | GRAPHIC | g487246g00x99.jpg | GRAPHIC | 11621
3 | GRAPHIC | g487246g07z44.jpg | GRAPHIC | 4138
4 | GRAPHIC | g487246g30y03.jpg | GRAPHIC | 290851
5 | GRAPHIC | g487246g61h17.jpg | GRAPHIC | 8959
6 | GRAPHIC | g487246g72v56.jpg | GRAPHIC | 322437
| Complete submission text file | 0001193125-13-170609.txt |  | 1211052

Mailing Address 201 ELLIOT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOT AVENUE WEST SEATTLE WA 98119 206.676.5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34475 | Film No.: 13779902
SIC: 2834 Pharmaceutical Preparations